셀메드 (CELLMED)

  • 제10권4호
  • /
  • Pages.31.1-31.6
  • /
  • 2020
  • /
  • 3022-6805(pISSN)
  • /
  • 3022-6791(eISSN)
셀메드 세포교정의약학회 (Cellmed Orthocellular Medicine and Pharmaceutical Association)
권호 표지
DOI QR코드

DOI QR Code

A Clinico-epidemiological Profile of Dyslipidaemia and its Association with Temperament - A Cross Sectional Study

  • Qurratulain, Qurratulain (Department of Moalajat, National Research Institute of Unani Medicine for Skin Disorders) ;
  • Nawab, Mohammad (Department of Moalajat, National Research Institute of Unani Medicine for Skin Disorders) ;
  • Kazmi, M.H. (National Research Institute of Unani Medicine for Skin Disorders)
  • 투고 : 2020.10.12
  • 심사 : 2020.11.12
  • 발행 : 2020.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Introduction: Dyslipidaemia is directly associated with cardiovascular diseases. Temperament, the unique constitutional make-up of an individual, is responsible for one's personality traits, physical appearances, and disease predispositions. The rising prevalence of dyslipidaemia becomes a challenge to control morbidity and mortality due to cardiovascular diseases. Objective: To study clinical patterns and risk factors of dyslipidaemia and its association with temperament at the individual level was the main objective of this study. Materials and Methods: It was a descriptive and analytical cross sectional study. The participants (n=88) were screened on the basis of raised serum lipid profile from the outpatient department of National Research Institute of Unani Medicine for Skin Disorders, Hyderabad. The data were collected on a case record form designed for this study and analyzed retrospectively. Results: In this study, there were 57% participants (n=50) of phlegmatic temperament in which mean total cholesterol, triglycerides, low density lipoprotein- cholesterol and high density lipoprotein-cholesterol were 230.92 (±49.48) mg/dl, 182.34 (±110.61) mg/dl, 153.24 (±50.21) mg/dl and 46.3 (±10.83) mg/dl respectively. Discussion: This study showed the prevalence of different clinical patterns of dyslipidaemia in the population and the phlegmatic participants were dyslipidaemic in a higher percentage. The prevalence of dyslipidaemia in phlegmatic participants may be linked to the constitutional make-up of the individual. The temperament of an individual may be considered as one of the risk factors for dyslipidaemia. Conclusion: It was concluded that the temperament of an individual may be used as a screening tool to predict the individual's tendency to develop dyslipidaemia.

키워드

참고문헌

  1. Abd M, Goyfman M, Chaus A, Dabbous F, Tamura L, Sandfort V, Brown A, & Budoff M. The Correlation of Dyslipidemia with the Extent of Coronary Artery Disease in the Multiethnic Study of Atherosclerosis. Journal of Lipid Research, 2018;1-9.
  2. Ahirwar R, & Mondal PR. Prevalence of obesity in India: A systematic review. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2019;13;318-321. https://doi.org/10.1016/j.dsx.2018.08.032
  3. Alam S, Alam A, Quamri MA, Sofi G, Khan MQ, & Ansari S. A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia. Tang [Humanituas Medicine], 2020;10(1);4-10. http://dx.doi.org/10.5667/tang.2020.0008
  4. Anonymous. Unani Medicine in India- An overview. (New Delhi, India: Central Council for Research in Unani Medicine), pp.25, 2016.
  5. Bays HE, Toth PP, Kris-etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-campoy JM, Jones SR, Kumar R, Forge Rla & Samuel VT. Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association. Journal of Clinical Lipidology, 2013;7;304-383. https://doi.org/10.1016/j.jacl.2013.04.001
  6. Berawi KN, Hadi S, Lipoeto NI, Wahid I, & Jamsari. Dyslipidemia Incidents Between General Obesity and Central Obesity of Employees with Obesity at Universitas Lampung. Biomedical and Pharmacology Journal, 2018;11(1);201-207. https://doi.org/10.13005/bpj/1364
  7. Carr MC, & Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. Journal of Clinical Endocrinology and Metabolism, 2004;89(6);2601-2607. https://doi.org/10.1210/jc.2004-0432
  8. Chang YC & Wu WC. Dyslipidemia and diabetic retinopathy. Review of Diabetic Studies, 2013;10(2-3);121-132. https://doi.org/10.1900/RDS.2013.10.121
  9. Fodor G. Primary Prevention of CVD : Treating Dyslipidemia. American Family Physician, 2011;83(10); 1207-1208.
  10. Garg R, Aggarwal S, Kumar R & Sharma G. Association of atherosclerosis with dyslipidemia and co-morbid conditions : A descriptive study. Journal of Natural Science, Biology and Medicine, 2015;6(1);163-168. https://doi.org/10.4103/0976-9668.149117
  11. Hirano T. Pathophysiology of Diabetic Dyslipidemia. Journal of Atherosclerosis and Thrombosis, 2018;25;771-782. https://doi.org/10.5551/jat.RV17023
  12. Hoosen M. Temperament- an important principle for health preservation in Tibb an-Nabawi and Unani-Tibb. Bangladesh Journal of Medical Science, 2017;16(4);487-495. https://doi.org/10.3329/bjms.v16i4.33600
  13. Karthikeyan G, Teo KK, Islam S, McQueen JM, Pais P, Wang X, Sato H, Lang chim choy, Amorn CS & Kazmi K. Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among Asians. Journal of the American College of Cardiology, 2009;53(3);244-253. https://doi.org/10.1016/j.jacc.2008.09.041
  14. Kawanami D, Matoba K & Utsunomiya K. Dyslipidemia in diabetic nephropathy. Renal Replacement Therapy, 2016;2(16);1-9. https://doi.org/10.1186/s41100-016-0028-0
  15. Mahalle N, Garg M, Naik S & Kulkarni M. Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease. Indian Journal of Endocrinology and Metabolism, 2014;18(1);48-55. https://doi.org/10.4103/2230-8210.126532
  16. Munjal YP. API Textbook of Medicine (9th ed.). (The Association of Physicians of India), 2012
  17. Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K & Kawada T. Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population. Journal of the American Heart Association, 2016;5(3);1-9. https://doi.org/10.1161/JAHA.115.003053
  18. Paccaud F, Schlüter-Fasmeyer V, Wietlisbach V & Bovet P. Dyslipidemia and abdominal obesity: an assessment in three general populations. Journal of Clinical Epidemiology, 2000;53(4);393-400. https://doi.org/10.1016/S0895-4356(99)00184-5
  19. Pretis Nde, Amodio A & Frulloni L. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management. United European Gastroenterology Journal, 2018;6(5);649-655. https://doi.org/10.1177/2050640618755002
  20. Saeed AA. Anthropometric predictors of dyslipidemia among adults in Saudi Arabia. Epidemiology Biostatistics and Public Health, 2013;10(1);1-11. https://doi.org/10.2427/8733
  21. Sarkar P, Mahadeva SK, Raghunath H, Nimisha V & Mandela TS. Utility of Anthropometric Indices as a Predictor of Dyslipidemia. Journal of Medical Sciences and Health, 2015;01(03); 10-13. https://doi.org/10.46347/jmsh.2015.v01i03.003
  22. WHO. The Global Health Observatory. World Health Organisation; World Health Organization, 2011. Available at: https://www.who.int/data/gho/data/themes/themedetails/GHO/body-mass-index-(bmi) [Accessed on 5th December 2020]
  23. WHO. Global Health Observatory (GHO) data, 2016. Available at: https://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/ [Accessed on 5th December 2020]